Pemigatinib, an FGFR inhibitor, overcomes resistance to KRASG12C inhibitors in mesenchymal-like NSCLC tumors

被引：0
|
作者：
Favata, Margaret
Weber, Michael
Abdollahi, Angela
Roman, Valerie Dostalik
Farren, Matt
Gilmartin, Aidan
Kim, Sunkyu
Wee, Susan
Rios-Doria, Jonathan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
430
引用
收藏
页数：2
相关论文
共 50 条
  • [21] KRAS Mutant Gene Editing Abolishes Tumor Growth In Vivo and Overcomes Acquired Resistance to KRASG12C and KRASG12D Small Molecule Inhibitors
    Desai, Neil
    Grunenberger, Audrey
    Guzman-Gonzalez, Veronica
    Cabrera, Lea
    Czuba, Elodie
    Faure, Virginie
    Josserand, Veronique
    Di Vita, Gilles
    MOLECULAR THERAPY, 2024, 32 (04) : 226 - 226
  • [22] Combination of KRASG12C(ON) and SHP2 inhibitors overcomes adaptive resistance and enhances anti-tumor immunity
    Anastasiou, Panayiotis
    Mugarza, Edurne
    Boumelha, Jesse
    Rana, Sareena
    Moore, Christopher
    Molina-Arcas, Miriam
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (12)
  • [23] CDK12/13 inhibition antagonizes resistance to KRASG12C inhibitors.
    Stern, Yaakov E.
    Ghosh, Pompom
    Walker-Mimms, Hannah L.
    Mosior, John W.
    Imbody, Denis
    Solanki, Hitendra S.
    Monastyrskyi, Andrii
    Duckett, Derek R.
    Haura, Eric B.
    CANCER RESEARCH, 2022, 82 (23)
  • [24] Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
    Lanman, Brian A.
    Allen, Jennifer R.
    Allen, John G.
    Amegadzie, Albert K.
    Ashton, Kate S.
    Booker, Shon K.
    Chen, Jian Jeffrey
    Chen, Ning
    Frohn, Michael J.
    Goodman, Guy
    Kopecky, David J.
    Liu, Longbin
    Lopez, Patricia
    Low, Jonathan D.
    Ma, Vu
    Minatti, Ana E.
    Nguyen, Thomas T.
    Nishimura, Nobuko
    Pickrell, Alexander J.
    Reed, Anthony B.
    Shin, Youngsook
    Siegmund, Aaron C.
    Tamayo, Nuria A.
    Tegley, Christopher M.
    Walton, Mary C.
    Wang, Hui-Ling
    Wurz, Ryan P.
    Xue, May
    Yang, Kevin C.
    Achanta, Pragathi
    Bartberger, Michael D.
    Canon, Jude
    Hollis, L. Steven
    McCarter, John D.
    Mohr, Christopher
    Rex, Karen
    Saiki, Anne Y.
    San Miguel, Tisha
    Volak, Laurie P.
    Wang, Kevin H.
    Whittington, Douglas A.
    Zech, Stephan G.
    Lipford, J. Russell
    Cee, Victor J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) : 52 - 65
  • [25] The selective WEE1 inhibitor azenosertib shows synergistic anti-tumor activity with KRASG12C inhibitors in multiple KRASG12C models
    Jameson, Nathan M.
    Kim, Gabriel
    Lee, Catherine
    Skrable, Blake
    Shea, Alexandra
    Abed, Monah
    Harismendy, Olivier
    Ma, Jianhui
    Kim, Doris
    Lackner, Mark R.
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Cardona, Andres Felipe
    Recondo, Gonzalo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
    Chour, Ali
    Toffart, Anne-Claire
    Berton, Elodie
    Duruisseaux, Michael
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] Establishment and characterization of XPDX models with acquired or conditioned resistance to KRASG12C inhibitors
    Moriarty, A.
    Flores, J.
    Johnson, S.
    Cesenes, P.
    Graciano, G.
    Lund, J.
    Banos, N.
    Papadopoulos, K.
    Patnaik, A.
    Rasco, D.
    Moreno, V.
    DeMiguel, M.
    Wick, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S145 - S146
  • [29] RAS:RAF proximity ligation assay may predict response to KRASG12C inhibitors in NSCLC
    Kato, Ryoji
    Solanki, Hitendra S.
    Imbody, Denis
    Majumder, Anurima
    Stern, Yaakov
    Bridenstine, Liznair
    Johnson, Joseph
    Haura, Eric B.
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [30] The clinical dual KRASG12C inhibitor FMC-376 has demonstrated potential as both a monotherapy and in combination for the treatment of patients with KRASG12C mutation positive NSCLC
    Wang, Yan
    Roberts, Allison
    Calses, Philamer
    Neve, Richard M.
    Staunton, Jocelyn
    Webster, Kevin R.
    CANCER RESEARCH, 2024, 84 (06)
12345